Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.

[1]  N. Müller,et al.  Glandular neoplasia of the lung. A proposed analogy to colonic tumors , 1988, Cancer.

[2]  Roberta R. Miller.  Bronchioloalveolar Cell Adenomas , 1990, The American journal of surgical pathology.

[3]  H. Kato,et al.  Clinicopathological Significance of Nuclear Accumulation of Tumor Suppressor Gene p53 Product in Primary Lung Cancer , 1992, Japanese journal of cancer research : Gann.

[4]  T. Sekiya,et al.  Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. , 1992, Cancer research.

[5]  V. Gouyer,et al.  Immunohistochemical study of p53 in human lung carcinomas. , 1993, The American journal of pathology.

[6]  Y. Nishiwaki,et al.  Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers , 1980, The American journal of surgical pathology.

[7]  S. Goodman,et al.  Overexpression of the p53 Tumor Suppressor Gene Product in Primary Lung Adenocarcinomas Is Associated with Cigarette Smoking , 1993, The American journal of surgical pathology.

[8]  R. Schwarting.  Little missed markers and Ki-67. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[9]  Barry Moran,et al.  The Lung , 1937, Canadian Medical Association journal.

[10]  I. J. Flance.  Scar cancer of the lung. , 1991, JAMA.

[11]  R. Mirimanoff,et al.  Clinical implications of the p53 tumor-suppressor gene. , 1994, The New England journal of medicine.

[12]  R. Bast,et al.  Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis. , 1994, American journal of clinical pathology.

[13]  H. Stein,et al.  New approach to assessing lung tumours in man. , 1986, Journal of clinical pathology.

[14]  U. Pastorino,et al.  Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. , 1992, Cancer research.

[15]  K. Nakanishi.  Alveolar epithelial hyperplasia and adenocarcinoma of the lung. , 1990, Archives of pathology & laboratory medicine.

[16]  A. Gown,et al.  Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. , 1992, The American journal of pathology.

[17]  Y. Satoh,et al.  Multiple atypical adenomatous hyperplasia of type II pneumonocytes and bronchiolo‐alveolar carcinoma , 1990, Histopathology.

[18]  I. Baas,et al.  Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. , 1993, The American journal of pathology.

[19]  Masanobu Kitaoawa.  AUTOPSY STUDY OF LUNG CANCER WITH SPECIAL REFERENCE TO SCAR CANCER , 1965 .

[20]  A. Liebow,et al.  Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung , 1965, Cancer.

[21]  H. Yokoo,et al.  Peripheral lung cancers arising in scars , 1961, Cancer.

[22]  R. Chiba,et al.  Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis , 1993, Cancer.

[23]  Y. Shimosato,et al.  Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. , 1986, American journal of clinical pathology.

[24]  W F Whimster,et al.  Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with agnor scores , 1990, The Journal of pathology.

[25]  D. Shibata,et al.  c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. , 1994, The American journal of pathology.

[26]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[27]  J. Pujol,et al.  In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers. , 1990, Cancer research.

[28]  S. Barsky,et al.  Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features , 1994, Cancer.

[29]  G. Fontanini,et al.  Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. , 1992, The American journal of pathology.

[30]  中山 治彦.  Clonal growth of atypical adenomatous hyperplasia of the lung : cytofluorometric analysis of nuclear DNA content , 1993 .

[31]  F. Clayton.  The spectrum and significance of bronchioloalveolar carcinomas. , 1988, Pathology annual.

[32]  R. Metcalf,et al.  p53 protein accumulates frequently in early bronchial neoplasia. , 1993, Cancer research.

[33]  P. Ganly,et al.  p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. , 1992, Oncogene.

[34]  N. Weidner,et al.  Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody. , 1994, Human pathology.

[35]  Y. Soini,et al.  Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. , 1993, The American journal of pathology.